Biotech news site Endpoints has hired three journalists to open an office in the United Kingdom.
Executive editor Drew Armstrong writes, “They’ll be led by Reynald Castañeda in London, who will work closely with Amber Tong in Hong Kong to oversee our morning and overnight news. In the coming weeks, Reynald and Amber will be joined by Ayisha Sharma and Anna Brown as breaking news reporters in London, who will help start our day earlier and bring their expertise to you.
“Reynald has a decade of experience as a healthcare journalist, most recently as Reuters Insight’s head of pharma research. Prior to that, he was an editor for Clinical Trials Arena and wrote long-form features and scoops as an investigative journalist for GlobalData Insights.
“Ayisha comes to us from Scrip and is based in London. She’s spent the last two years covering the commercial implications of clinical trials, deals and drug approvals and will report on developing business and science news out of Europe and early in the US day.
“Anna joins us from Informa Connect, where she was a senior digital producer developing and moderating events for BioProcess International. The production of complex new therapies is one of the most important stories in biotech, and in addition to breaking news, she will help grow our coverage of the manufacturing side of the industry. She has a master’s degree in biomedical sciences from the University of Bristol and is also based in London.”
Read more here.
